FrenvasTM 20 mg

FrenvasTM 20 mg

FrenvasTM is indicated as an adjunct to diet for reduction of elevated total cholesterol, LDL-cholesterol, triglycerides (TG).

FrenvasTM is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme responsible for the conversion of 3- hydroxy- 3- methyl- glutaryl- coenzyme A to mevalonate, a precursor of sterols, including cholesterol. Triglycerides (TG) and cholesterol in the liver are incorporated into VLDL and released into the plasma for delivery to peripheral tissues. Low-density lipoprotein (LDL) is formed from VLDL and is catabolised primarily through the high affinity LDL receptor. FrenvasTM lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL. FrenvasTM reduces LDL production and the number of LDL particles. FrenvasTM produces a profound and sustained increase in LDL receptor activity coupled with a beneficial change in the quality of circulating LDL particles


FrenvasTM 10 mg film coated tablet contains 10 mg Atorvastatin Calcium USP. FrenvasTM 20 mg film coated tablet contains 20 mg Atorvastatin Calcium USP.

একটি পর্যবেক্ষণ লিখুন

নোটঃ এইচটিএমএল এর অনুবাদ হয় না!
    খারাপ           ভাল

  • Views: 39
  • পণ্য কোডঃ tablet
  • উপস্থিতিঃ ষ্টকে আছেঃ
0 Product(s) Sold
  • ৳0
  • অতিরিক্ত ট্যাক্সঃ ৳0